Standard Partners key facts
- Standard Partners is a hedge fund based in Bethesda, United States with 2 tracked portfolio companies.
- Notable positions include Anto Biosciences, Novoflow.
- Standard Partners reports $3.2M in regulatory assets under management across 1 private fund, per its SEC Form ADV (2026-03).
About Standard Partners
297400-42P
Investment focus
Its SEC Form ADV lists $3.2 million in regulatory assets under management across 1 private fund (Mar 2026).
Standard Partners portfolio at a glance
2 portfolio companies are on record for Standard Partners: Anto Biosciences and Novoflow.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
Standard Partners at the SEC
Form ADV · 2026-03 · CRD 167956- Regulatory AUM
- $3.2M
- Private fund assets
- $96.1M
- Private funds
- 1 · 1 hedge
- Staff
- 2
- Registered office
- BETHESDA, MD
- SEC status
- Approved
Reports custody of client assets.
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as STANDARD PARTNERS LLC).
Free account
See more of the book
- ·Watchlist + alerts for Standard Partners's activity
Portfolio
2 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Anto Biosciences | — | ▮ | ▮ | ▮ |
| Novoflow | — | ▮ | ▮ | ▮ |
All 2 companies — valuations, dates and lead flags are a member feature Membership and data by Private Market View | ||||
Frequently asked about Standard Partners
- What companies does Standard Partners invest in?
- Standard Partners has 2 recorded portfolio companies, including Anto Biosciences, Novoflow.